PGNY Stock Analysis: Buy, Sell, or Hold?
PGNY - Progyny, Inc. Common Stock
$22.87
-0.64 (-2.72%)
▼
5d:
+19.36%
30d:
+31.51%
90d:
+9.01%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Distribution
PGNY is up 4.0% this week, but smart money is buying puts. Top strike: $17.5 2026-06-18 with 22 OI. Put ratio: 69% View Scanner →
Strength: 3.9/10
Get Alerted When PGNY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: PGNY is 10.4% above its trading range ($20.72). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: PGNY is 10.4% above its trading range ($20.72). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$28.13
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$17.47
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PGNY is currently trading at $22.87, which is considered extended relative to its 30-day fair value range of $16.65 to $20.72. The stock's valuation (Forward PE: 10.7) is in line with its historical norms (10.7). Remarkably, the market is currently pricing in an annual earnings decline of 0.1% over the next few years. This pessimistic expectation contrasts with the company's recent 70.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PGNY is in a strong downtrend. Immediate support is located at $18.49, while resistance sits at $24.39.
Market Sentiment: PGNY has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.09 (+22.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PGNY is in a strong downtrend. Immediate support is located at $18.49, while resistance sits at $24.39.
Market Sentiment: PGNY has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.09 (+22.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$16.65 -
$20.72
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding PGNY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+10.4% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.8% below Wall St target ($28.09)
Trading Range Analysis
30-Day Trading Range
$16.65 -
$20.72
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$18.49
Resistance Level
$24.39
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.66
Wall Street Target
$28.09
(+22.8%)
Revenue Growth (YoY)
1.4%
Earnings Growth (YoY)
70.6%
Profit Margin
5.2%
Valuation Discount vs History
-0.1% cheaper
PE vs Historical
10.7 vs 10.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.1%
(market-implied from PE analysis)
1-Year Target
$22.85
(0%)
2-Year Target
$22.82
(0%)
3-Year Target
$22.80
(0%)
3-Yr Target (if PE normalizes)
(PE: 11→11)
$22.89
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 4.3%)
$53.60
(+134%)
Base:
(SPY PE: 10.7, Growth: 4.3%)
$25.92
(+13%)
Bear:
(PE: 9.1, Growth: 4.3%)
$22.04
(-4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 30.53 | Current EPS (TTM): $0.77
Bull Case
$51.72
(+126%)
Analyst growth 100.0%, PE expands to 33.6
Base Case
$47.02
(+106%)
Market implied 100.0%, PE stable at 30.5
Bear Case
$15.99
(-30%)
Severe decline -20.0%, PE contracts to 26.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.7 to 10.7
Stabilization Target:
$22.95
(+0.4%)
PE Expansion Potential:
+0.4%
Share & Embed Analysis
Last updated: May 14, 2026 10:00 PM ET
Data refreshes hourly during market hours. Next update: 11:00 PM
Data refreshes hourly during market hours. Next update: 11:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGNY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Allison Swartz
SELL
599 shares
2026-03-04
Allison Swartz
SELL
4657 shares
2026-03-03
Allison Swartz
SELL
2199 shares
2026-03-02
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$387 | 63 BUY |
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$100 | 55 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 62 BUY |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$389 | 55 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$244 | 57 HOLD |
Advanced PGNY Option Strategies
Professional options setups generated by AI based on today's PGNY price and gamma walls.
